![Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/3705bc47-7921-4c1b-8878-d96df55e3af9/gr1.gif)
Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology
![Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/979349cd-7b01-4930-8f54-33055bf767e2/gr1.gif)
Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology
![Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12902-020-00618-0/MediaObjects/12902_2020_618_Fig1_HTML.png)
Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text
![Effect of metformin on maternal and neonatal outcomes in pregnant obese non-diabetic women: A meta-analysis - International Journal of Reproductive BioMedicine Effect of metformin on maternal and neonatal outcomes in pregnant obese non-diabetic women: A meta-analysis - International Journal of Reproductive BioMedicine](https://ijrm.ir/files/site1/images/2017/August-2017/1)95-140-3/figure_4.jpg)
Effect of metformin on maternal and neonatal outcomes in pregnant obese non-diabetic women: A meta-analysis - International Journal of Reproductive BioMedicine
Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin
![Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial | BMC Musculoskeletal Disorders | Full Text Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12891-022-05434-2/MediaObjects/12891_2022_5434_Fig1_HTML.png)
Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial | BMC Musculoskeletal Disorders | Full Text
![Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - ScienceDirect Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939475312002207-gr1.jpg)
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - ScienceDirect
![Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation](https://www.ahajournals.org/cms/asset/84d8b41f-0363-4584-9bad-c45344452da5/2895fig04.gif)
Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation
![PDF) Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 – secondary analysis of a randomized controlled trial PDF) Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 – secondary analysis of a randomized controlled trial](https://i1.rgstatic.net/publication/342871313_Metformin_and_insulin_treatment_of_gestational_diabetes_effects_on_inflammatory_markers_and_IGF-binding_protein-1_-_secondary_analysis_of_a_randomized_controlled_trial/links/5fc21076a6fdcc6cc6778a41/largepreview.png)